Form 4: Modular Medical Director Philip Sheibley Acquires Options Under Director Compensation Plan

Sentiment:

SEC Form 4 Filing


Director Philip Sheibley acquired options to purchase 7,500 shares of Modular Medical common stock on December 31, 2024, under the company's Outside Director Compensation Plan.

Summary

  • On December 31, 2024, Philip Brent Sheibley, a director of Modular Medical, Inc., was granted an option to purchase 7,500 shares of the company's common stock.
  • The options were granted under the Issuer's Outside Director Compensation Plan.
  • The exercise price of the options is $1.39 per share.
  • The options were fully vested and exercisable on the grant date, December 31, 2024.
  • The options expire on December 31, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The immediate vesting is a slightly positive signal.

Positives

  • The grant of options to a director aligns their interests with those of the shareholders.
  • Immediate vesting suggests the company values the director's ongoing contributions.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a transaction related to director compensation, which is a common practice in publicly traded companies.

Stakeholder Impact

  • The granting of options to a director aligns their interests with those of the shareholders, potentially leading to better decision-making.

Key Dates

DateDescription
12/31/2024Date of earliest transaction: Grant of options to purchase common stock.
12/31/2024Options fully vested and exercisable.
12/31/2034Expiration date of the options.
01/03/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.